WO1998042371A1 - Nouvelle utilisation d'antithrombine iii - Google Patents

Nouvelle utilisation d'antithrombine iii Download PDF

Info

Publication number
WO1998042371A1
WO1998042371A1 PCT/AT1998/000078 AT9800078W WO9842371A1 WO 1998042371 A1 WO1998042371 A1 WO 1998042371A1 AT 9800078 W AT9800078 W AT 9800078W WO 9842371 A1 WO9842371 A1 WO 9842371A1
Authority
WO
WIPO (PCT)
Prior art keywords
iii
preparation
heparin
heparins
use according
Prior art date
Application number
PCT/AT1998/000078
Other languages
German (de)
English (en)
Inventor
Hans-Peter Schwartz
Anton Philapitsch
Ludwig Pichler
Wilfried Auer
Yendra Linnau
Original Assignee
Baxter Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Aktiengesellschaft filed Critical Baxter Aktiengesellschaft
Priority to CA002284820A priority Critical patent/CA2284820A1/fr
Priority to AU63852/98A priority patent/AU6385298A/en
Priority to EP98909214A priority patent/EP0971732A1/fr
Publication of WO1998042371A1 publication Critical patent/WO1998042371A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans

Abstract

L'invention concerne l'utilisation d'antithrombine III (AT III) pour produire une préparation pharmaceutique servant à empêcher les hémorragies pendant un traitement anticoagulant, ainsi qu'une préparation pharmaceutique pour injection sous-cutanée contenant l'AT III comme principe actif.
PCT/AT1998/000078 1997-03-25 1998-03-24 Nouvelle utilisation d'antithrombine iii WO1998042371A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CA002284820A CA2284820A1 (fr) 1997-03-25 1998-03-24 Nouvelle utilisation de l'antithrombine iii
AU63852/98A AU6385298A (en) 1997-03-25 1998-03-24 New application for antithrombin iii
EP98909214A EP0971732A1 (fr) 1997-03-25 1998-03-24 Nouvelle utilisation d'antithrombine iii

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT51797A AT405905B (de) 1997-03-25 1997-03-25 Neue verwendung von antithrombin iii
ATA517/97 1997-03-25

Publications (1)

Publication Number Publication Date
WO1998042371A1 true WO1998042371A1 (fr) 1998-10-01

Family

ID=3492718

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/AT1998/000078 WO1998042371A1 (fr) 1997-03-25 1998-03-24 Nouvelle utilisation d'antithrombine iii

Country Status (5)

Country Link
EP (1) EP0971732A1 (fr)
AT (1) AT405905B (fr)
AU (1) AU6385298A (fr)
CA (1) CA2284820A1 (fr)
WO (1) WO1998042371A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2503995A2 (fr) * 2009-11-24 2012-10-03 Grifols Therapeutics Inc. Procédés, compositions et trousses de lyophilisation

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0048898A2 (fr) * 1980-09-30 1982-04-07 Bayer Ag Procédé de preparation d'un complexe antithrombine-héparine et compositions pharmaceutiques le contenant
US4689323A (en) * 1983-09-26 1987-08-25 Miles Laboratories, Inc. Covalently bound heparin--antithrombin-III complex
JPH09132534A (ja) * 1995-11-10 1997-05-20 Green Cross Corp:The アンチトロンビン−ｉｉｉの液状製剤およびその保存 安定化方法
WO1997019701A2 (fr) * 1995-11-30 1997-06-05 Hamilton Civic Hospitals Research Development, Inc. Conjugues de glycosaminoglycanes-antithrombine iii/co-facteur ii de l'heparine
EP0781558A2 (fr) * 1995-12-27 1997-07-02 Minoru Tsukada Utilisation pharmaceutique du cofacteur II de l'héparine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3494667B2 (ja) * 1992-10-02 2004-02-09 アベンティス ファーマ株式会社 アンチトロンビンｉｉｉ製剤

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0048898A2 (fr) * 1980-09-30 1982-04-07 Bayer Ag Procédé de preparation d'un complexe antithrombine-héparine et compositions pharmaceutiques le contenant
US4689323A (en) * 1983-09-26 1987-08-25 Miles Laboratories, Inc. Covalently bound heparin--antithrombin-III complex
JPH09132534A (ja) * 1995-11-10 1997-05-20 Green Cross Corp:The アンチトロンビン−ｉｉｉの液状製剤およびその保存 安定化方法
WO1997019701A2 (fr) * 1995-11-30 1997-06-05 Hamilton Civic Hospitals Research Development, Inc. Conjugues de glycosaminoglycanes-antithrombine iii/co-facteur ii de l'heparine
EP0781558A2 (fr) * 1995-12-27 1997-07-02 Minoru Tsukada Utilisation pharmaceutique du cofacteur II de l'héparine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PATENT ABSTRACTS OF JAPAN vol. 097, no. 009 30 September 1997 (1997-09-30) *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2503995A2 (fr) * 2009-11-24 2012-10-03 Grifols Therapeutics Inc. Procédés, compositions et trousses de lyophilisation
EP2503995A4 (fr) * 2009-11-24 2014-05-21 Grifols Therapeutics Inc Procédés, compositions et trousses de lyophilisation
RU2540480C2 (ru) * 2009-11-24 2015-02-10 Грифольс Терапьютикс Инк. Способы, композиции и наборы для лиофилизации

Also Published As

Publication number Publication date
AU6385298A (en) 1998-10-20
CA2284820A1 (fr) 1998-10-01
AT405905B (de) 1999-12-27
EP0971732A1 (fr) 2000-01-19
ATA51797A (de) 1999-05-15

Similar Documents

Publication Publication Date Title
DE4344824C1 (de) Hochkonzentriertes Immunglobulin-Präparat und Verfahren zu seiner Herstellung
DE2751717C2 (fr)
EP0430200B1 (fr) Médicament pour application s.c. ou i.m. contenant des polypeptides
EP0331152A1 (fr) Seringue à deux compartiments remplie d'une protéine humaine sensible comme principe actif
CH645537A5 (en) Antithrombin product and process for its production
DE4200080A1 (de) Pharmazeutische Zusammensetzung zur Wund-, Narben- und Keloidbehandlung
DE2324717B2 (de) Verfahren zur Herstellung eines stabilen AHF-Konzentrates (Faktor VUI)
DE69827357T2 (de) Menschliches Wachstumshormon enthaltende pharmazeutische Zusammensetzung
DE3150318C2 (de) "Verfahren zur Herstellung eines Polysaccharidderivats des Fibrinolysins"
EP1226829B1 (fr) Préparations liquides stabilisées de la protéase ou de son proenzyme qui activent le facteur VII de la coagulation sanguine
EP0500602B1 (fr) Agent de neutralisation de l'activite procoagulante associee aux cellules tumorales
DE60316967T2 (de) Kondensiertes protein, das sowohl thrombolytisch als auch gerinnungshemmend wirkt, und dessen verwendung
EP0625908B1 (fr) Antidote pour l'hirudine et les inhibiteurs synthetiques de la thrombine
EP0193175A2 (fr) Hirudines modifiées, leur procédé de préparation et agents pharmaceutiques les contenant
EP0637451A1 (fr) Préparation de facteur XIII de coagulation du sang depourvue de tout virus
EP0328957B1 (fr) Mélange d'une substance à activité thrombolytique et d'une substance à activité antithrombolytique
DE69531150T2 (de) Verwendung von biopolymeren zur behandlung der muskeln
EP0493662B1 (fr) Utilisation de superoxyde dismutases pour la préparation de médicaments pour la prophylaxie et/ou le traitement de la défaillance d'organes de patients à risques ayant un traumatisme multiple causé par un accident
DE60128399T2 (de) Verwendung von thrombomodulinanaloga zur regenerierung von rückenmarkverletzungen
AT405905B (de) Neue verwendung von antithrombin iii
DE1668171A1 (de) Verfahren zur herstellung von stabilen waessrigen loesungen neuer komplexer organosiliciumverbindungen
WO2001051525A1 (fr) Heparine presentant une masse molaire moyenne
DE2815853A1 (de) Gereinigte urokinasepraeparate und verfahren zu ihrer herstellung
AT405241B (de) Verwendung von humanem alpha1-sauren glycoprotein zur herstellung einer pharmazeutischen präparation
CH638400A5 (de) Verfahren zur herstellung einer glucosehaltigen infusionsloesung.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Kind code of ref document: A

Ref document number: 2284820

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1998909214

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 09381705

Country of ref document: US

ENP Entry into the national phase

Ref document number: 1998 9053

Country of ref document: AT

Date of ref document: 19981001

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 19989053

Country of ref document: AT

WWP Wipo information: published in national office

Ref document number: 1998909214

Country of ref document: EP

NENP Non-entry into the national phase

Ref document number: 1998544521

Country of ref document: JP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1998909214

Country of ref document: EP